Company logo

BIO - Bio-Rad Laboratories, Inc.

NYSE -> Healthcare -> Medical Devices
Hercules, United States
Type: Equity

BIO price evolution
BIO
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $403.81 $457.85 $390 $464.14
Short term investments $1208.89 $1306.7 $1338.24 $1392.88
Net receivables $489.02 $457.4 $491.57 $498.27
Inventory $780.52 $775.82 $776.6 $752.94
Total current assets $3048.33 $3146.77 $3138.87 $3277.25
Long term investments $7698.07 $7218.16 $7311.14 $8878.51
Property, plant & equipment $723.74 $711.4 $687.93 $680.55
Goodwill & intangible assets $734.08 $721.14 $740.23 $735.59
Total noncurrent assets $9250.74 $8749.17 $8839.36 $10390.16
Total investments $8906.96 $8524.86 $8649.38 $10271.39
Total assets $12299.07 $11895.94 $11978.23 $13667.41
Current liabilities
Accounts payable $144.63 $111.86 $149.53 $160.98
Deferred revenue
Short long term debt $40.87 $39.59 $37.02 $36.67
Total current liabilities $522.8 $558.18 $581.98 $589.62
Long term debt $1364.53 $1365.89 $1345.23 $1345.05
Total noncurrent liabilities $3035.14 $2921.57 $2949.35 $3314.07
Total debt $1405.39 $1405.48 $1382.25 $1381.71
Total liabilities $3557.94 $3479.74 $3531.34 $3903.7
Shareholders' equity
Retained earnings $9260.63 $8910.92 $8804.66 $9966.96
Other shareholder equity -$336.04 -$497.56 -$372.86 -$408.35
Total shareholder equity $8741.13 $8416.2 $8446.89 $9763.72
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $403.81 $434.21 $470.78 $662.21
Short term investments $1208.89 $1362.02 $404.69 $334.47
Net receivables $489.02 $494.64 $423.54 $419.42
Inventory $780.52 $719.32 $572.24 $622.25
Total current assets $3048.33 $3157.98 $1989.09 $2139.84
Long term investments $7698.07 $8830.89 $14387.01 $9561.14
Property, plant & equipment $723.74 $679.56 $695.75 $693.51
Goodwill & intangible assets $734.08 $738.63 $601.28 $491.41
Total noncurrent assets $9250.74 $10343.69 $15786.71 $10832.78
Total investments $8906.96 $10192.91 $14791.7 $9895.61
Total assets $12299.07 $13501.67 $17775.79 $12972.62
Current liabilities
Accounts payable $144.63 $329.83 $141.94 $139.45
Deferred revenue $52.21 $50.85 $42.47
Short long term debt $40.87 $36.8 $36.92 $38.3
Total current liabilities $522.8 $568.71 $680.94 $631.54
Long term debt $1364.53 $1197.72 $186.45 $187.39
Total noncurrent liabilities $3035.14 $3317.71 $3427.72 $2461.14
Total debt $1405.39 $1388.11 $223.38 $225.69
Total liabilities $3557.94 $3886.41 $4108.66 $3092.68
Shareholders' equity
Retained earnings $9260.63 $9898.2 $13507.24 $9268.01
Other shareholder equity -$336.04 $9615.25 -$175.55 $282.46
Total shareholder equity $8741.13 $9615.25 $13667.13 $9879.94
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $681.18 $632.12 $681.11 $676.84
Cost of revenue $314.82 $296.44 $318.63 $314.43
Gross Profit $366.36 $335.68 $362.48 $362.42
Operating activities
Research & development $63.9 $43.53 $65.04 $74.95
Selling, general & administrative $207.15 $201.2 $207.82 $225.55
Total operating expenses $271.05 $244.73 $272.87 $300.5
Operating income $95.32 $90.95 $89.62 $61.91
Income from continuing operations
EBIT $440.75 $149.5 -$1488.08 $97.17
Income tax expense $78.68 $30.84 -$338.18 $15.87
Interest expense $12.36 $12.4 $12.34 $12.34
Net income
Net income $349.71 $106.26 -$1162.25 $68.96
Income (for common shares) $349.71 $106.26 -$1162.25 $68.96
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $2671.26 $2802.25 $2922.55 $2545.63
Cost of revenue $1244.32 $1234.92 $1281.88 $1107.8
Gross Profit $1426.95 $1567.33 $1640.66 $1437.82
Operating activities
Research & development $247.43 $256.89 $271.66 $226.6
Selling, general & administrative $841.72 $827.83 $879.57 $800.27
Total operating expenses $1089.15 $1084.71 $1151.23 $1026.87
Operating income $337.8 $482.62 $489.43 $410.96
Income from continuing operations
EBIT -$800.66 -$4666.16 $5439.7 $4929.5
Income tax expense -$212.78 -$1076.74 $1192.25 $1101.37
Interest expense $49.44 $38.11 $1.55 $21.86
Net income
Net income -$637.32 -$3627.53 $4245.9 $3806.27
Income (for common shares) -$637.32 -$3627.53 $4245.9 $3806.27
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $349.71 $106.26 -$1162.25 $68.96
Operating activities
Depreciation
Business acquisitions & disposals $2.5
Stock-based compensation
Total cash flows from operations $81.05 $97.71 $98.07 $98.12
Investing activities
Capital expenditures -$42.14 -$44.01 -$34.6 -$35.73
Investments $111.83 $34.51 $62.58 -$34.75
Total cash flows from investing $72.2 -$9.5 $27.98 -$70.47
Financing activities
Dividends paid
Sale and purchase of stock -$195.68 -$16.67 -$202.31 $4.42
Net borrowings -$0.12 -$0.12 -$0.12 -$0.12
Total cash flows from financing -$200.62 -$26.6 -$202.74 $4.31
Effect of exchange rate -$6.57 $6.22 $2.67 -$2
Change in cash and equivalents -$53.95 $67.83 -$74.02 $29.96
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$637.32 -$3627.53 $4245.9 $3806.27
Operating activities
Depreciation
Business acquisitions & disposals $2.5 -$99.39 -$125.52 -$84.42
Stock-based compensation
Total cash flows from operations $374.94 $194.45 $656.52 $575.33
Investing activities
Capital expenditures -$156.47 -$112.62 -$120.75 -$98.85
Investments $174.18 -$994.21 -$538.17 $119.6
Total cash flows from investing $20.21 -$1207.59 -$784.44 -$60.25
Financing activities
Dividends paid
Sale and purchase of stock -$410.24 -$198.12 -$29.37 -$79.81
Net borrowings -$0.47 $1185.71 -$3.02 -$426.94
Total cash flows from financing -$425.65 $973.58 -$55.43 -$523.04
Effect of exchange rate $0.32 $2.98 -$12.64 $12.43
Change in cash and equivalents -$30.18 -$36.59 -$195.98 $4.46
Fundamentals
Market cap $10.08B
Enterprise value $11.08B
Shares outstanding 29.15M
Revenue $2.67B
EBITDA -$800.66M
EBIT -$800.66M
Net Income -$637.32M
Revenue Q/Q -6.72%
Revenue Y/Y N/A
P/E ratio -15.82
EV/Sales 4.15
EV/EBITDA -13.84
EV/EBIT -13.84
P/S ratio 3.77
P/B ratio 1.11
Book/Share 311.45
Cash/Share 13.86
EPS -$21.87
ROA -5.11%
ROE -7.21%
Debt/Equity 0.41
Net debt/EBITDA -3.94
Current ratio 5.83
Quick ratio 4.34